Gene · 2867
Papers2,791
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,791
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review of osteoarthritis signaling intervention using small-molecule inhibitors. | Medicine (Baltimore) | 2022 | 35960127 | PubTator, text mining | PubMed |
| Gut microbes and food reward: From the gut to the brain. | Front Neurosci | 2022 | 35958993 | PubTator, text mining | PubMed |
| Short-Chain Carbon Sources: Exploiting Pleiotropic Effects for Heart Failure Therapy. | JACC Basic Transl Sci | 2022 | 35958686 | PubTator, text mining | PubMed |
| An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia. | Am J Transl Res | 2022 | 35958446 | PubTator, text mining | PubMed |
| Mapping trends and hotspot regarding gut microbiota and host immune response: A bibliometric analysis of global research (2011-2021). | Front Microbiol | 2022 | 35958122 | PubTator, text mining | PubMed |
| Inflammatory Signatures of Maternal Obesity as Risk Factors for Neurodevelopmental Disorders: Role of Maternal Microbiota and Nutritional Intervention Strategies. | Nutrients | 2022 | 35956326 | PubTator, text mining | PubMed |
| Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. | Int J Mol Sci | 2022 | 35955491 | PubTator, text mining | PubMed |
| Microbiota and the Immune System-Actors in the Gastric Cancer Story. | Cancers (Basel) | 2022 | 35954495 | PubTator, text mining | PubMed |
| Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists. | J Med Chem | 2022 | 35948061 | PubTator, text mining | PubMed |
| Colonic Delivery of Nutrients for Sustained and Prolonged Release of Gut Peptides: A Novel Strategy for Appetite Management. | Mol Nutr Food Res | 2022 | 35938221 | PubTator, text mining | PubMed |
| Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. | Front Nutr | 2022 | 35938108 | PubTator, text mining | PubMed |
| Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy. | Front Endocrinol (Lausanne) | 2022 | 35937817 | PubTator, text mining | PubMed |
| Natural fish oil improves the differentiation and maturation of oligodendrocyte precursor cells to oligodendrocytes in vitro after interaction with the blood-brain barrier. | Front Immunol | 2022 | 35935952 | PubTator, text mining | PubMed |
| Transfer mechanism of cell-free synthesized membrane proteins into mammalian cells. | Front Bioeng Biotechnol | 2022 | 35935506 | PubTator, text mining | PubMed |
| The gut microbiome and Alzheimer's disease: Complex and bidirectional interactions. | Neurosci Biobehav Rev | 2022 | 35934087 | PubTator, text mining | PubMed |
| Looking for the Genes Related to Lung Cancer From Nasal Epithelial Cells by Network and Pathway Analysis. | Front Genet | 2022 | 35923697 | PubTator, text mining | PubMed |
| Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection. | Gut Microbes | 2022 | 35915556 | PubTator, text mining | PubMed |
| Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021. | Hypertension | 2022 | 35912645 | PubTator, text mining | PubMed |
| The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine. | Front Oncol | 2022 | 35912227 | PubTator, text mining | PubMed |
| Efficacy of dietary supplements targeting gut microbiota in the prevention and treatment of gestational diabetes mellitus. | Front Microbiol | 2022 | 35910625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2867/papers?page=48